Core Biogenesis
Core Biogenesis produces pharma-grade recombinant proteins with its plant-based bioproduction platform. Our first products are growth factors used for Cell Therapy manufacturing and Cultivated meat production.
- biotechnology
- horizon europe
- sustainable development goals
- dt and ls
- climate tech
- radar de l'innovation
- tech for business
- observatoire industrial tech
- observatoire greentech
- observatoire deeptech
- alternative protein
- biotech, medtech and e-health
- proteomics
- eicfund
- observatoire healthtech
- synthetic biology
- greentech
- biomaterials
- bioeconomy
- molecular
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | €0.0 | round |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
€1.9m | Grant | ||
| Total Funding | 000k | ||
| EUR | 2021 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
Developer of bioproduction technologies designed to use plants as biofactories to scale the production of high-value bioproducts. The company's ultra-scalable bioproduction as a service (UBaaS) platform accelerates mass production and isolates molecules to a specific plant compartment, making extraction faster, and more scalable and it also offers proprietary gene editing and plant biotechnology to produce GF(Growth Factors) molecules used in the clean meat and cell therapy industries, which regulate the growth, division, and survival of cells, enabling clients to increase yields while driving down costs.
Keywords: Pharmaceuticals and Biotechnology, Bioproduction Facility, Biotech Company, Biotechnology Processing, Cytokines Synthesis, Growth Factoring Molecules, Protein Production, Recombinant Molecule Production, Recombinant Protein Bioproduction.